Measuring and Valuing Outcomes
We have established an excellent reputation for leading innovative, ideas-driven, and theoretically sound research on the measurement and valuation of outcomes. Health care systems should put patient-relevant outcomes at the heart of decisions about funding and providing health and social care.
Can We Really Compare and Aggregate Patient-reported Outcomes Between People and Settings?
11 April 2019
A new OHE Research Paper considers whether we can compare and aggregate patient-reported outcome (PRO) data between people and settings. The paper is authored by Nancy…
Quality of Life and Rare Disease: Lessons from Spinal Muscular Atrophy
2 April 2019
The measurement of quality of life in the context of spinal muscular atrophy (SMA) is challenging. This is because the disease is experienced by children and…
Pricing and Paying for Cures: Early Experience with HTA of Gene Therapy in the USA
28 February 2019
In this OHE Seminar Briefing, Dr Steven Pearson, President of ICER, sets out ICER’s early experiences of using HTA to assess gene therapy in the US,…
Student Mental Health Research Network (SMaRteN): First Funding Call and Sandpit
26 February 2019
OHE is a collaborator on SMaRteN, and we’ve just announced the first funding call on “What is distinctive about student mental health?”
Recommendations for Making Outcome-based Payments a Reality in the NHS: An Application to Cancer Drugs
21 February 2019
Making Outcome-based payments a reality in the NHS authored by The Office of Health Economics, RAND Europe, King’s College London, and Cancer Research UK, and commissioned…
Generating Preference-based Values for the EQ-5D-Y to Support Its Use in HTA
31 January 2019
OHE’s Koonal Shah and Oliver Rivero-Arias presented at a NICE Technical Forum on the topic of valuing health in children and adolescents.
Public Preferences for Health Gains and Cures: A Discrete Choice Experiment
22 January 2019
Just published is a new OHE Consulting Report that explores society’s preferences across curative and non-curative therapies and large and small health gains.
Valuing EQ-5D-Y Health States Using a Discrete Choice Experiment: Do Adult and Adolescent Preferences Differ?
7 January 2026
This Research Paper describes a study examining adolescent and adult responses to a discrete choice experiment (DCE) containing EQ-5D-Y health states in order to determine whether…
Can We Really Compare and Aggregate PRO Data Between People and Settings? Implications for Multi-Country Clinical Trials and HTA
4 January 2019
The aim of this paper is to provide an overview of the issues that might limit comparability of PRO data and to highlight some of the…